Biotest AG VZ Stock
Your prediction
Pros and Cons of Biotest AG VZ in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biotest AG VZ vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biotest AG VZ | - | - | - | - | - | - | - |
| MPH Health Care AG | -2.700% | -2.232% | -8.750% | -4.783% | 0.000% | 41.290% | -12.400% |
| Pacira Pharmaceuticals | -4.040% | -3.553% | 15.152% | -21.488% | -12.037% | -50.000% | -68.595% |
| Rockwell Medical Inc. | -1.650% | -4.627% | -17.853% | -50.417% | 14.265% | -55.318% | -93.836% |
News
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.